To Investigate the Effect of Modified Cawthorne-cooksey Exercises on Cervical Proprioception and Functional Outcomes in Patients With Cervical Radiculopathy. Fifty Four Patients With Cervical Radiculopathy From Both Sexes Will be Selected Randomly and Allocated Into Two Equal Groups. (Cawthorne)

January 11, 2026 updated by: Ahmed Khairy Abdullah Hussein, German International University

Effect of Modified Cawthorne-Cooksey Exercises on Cervical Proprioception and Functional Outcomes in Patients With Cervical Radiculopathy

To investigate the effect of cawthorne-cooksey exercises on cervical proprioception and functional outcomes in patients with cervical radiculopathy

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Fifty four patients with cervical radiculopathy from both sexes will be selected randomly outpatient clinic and allocated into two equal groups. The Control Group will receive the selected physical therapy program only (electrotherapy, manual therapy, strengthening exercises), study Group will receive the Cawthorne-Cooksey exercises program and the selected physical therapy program. Basic assumptions

It will be assumed that:

  • All the patients will follow the instructions and the rehabilitation program that are given to them.
  • The motivation and cooperation are the same for all patients
  • The patients will exert their maximum efforts during the study.

Null Hypothesis:

It will be hypothesized that:

  • There will be no significant effect of Cawthorne-Cooksey exercises on proprioception in patients with cervical radiculopathy.
  • There will be no significant effect of Cawthorne-Cooksey exercises on functional outcomes in patients with cervical radiculopathy.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
54

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Pivot clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Their ages range from 30 to 45 years.
  2. Both sexes
  3. With mild to moderate cervical disability according to the neck disability index.
  4. Unilateral cervical radiculopathy for more than 6 months.
  5. Cervical radiculopathy due to disc prolapse (C5-C6) (C6-C7) mild to moderate or disc prolapse according to magnetic resonance image(MRI).
  6. Complaining from vertigo at least for 3 months.
  7. Normal body mass index (18.5 - 24.99Kg/m2).

Exclusion Criteria:

  1. Any other musculoskeletal disorders of the spine or upper extremity
  2. Patients with any other Neurological deficits, psychiatric disease Cervical myelopathy, Cognitive problems, vertebral fractures and previous history of spine or cervical surgery.
  3. Clinical instability, recent trauma.
  4. Structural abnormalities of the spine, osteoporosis, and spasmodic torticollis.
  5. Inflammatory or other specific disorders of spine such as ankylosing spondylitis and rheumatoid arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Cawthorne-Cooksey exercises
Cawthorne-Cooksey exercises are one form of vestibular exercises under this training involving centers such as visual, proprioceptive, and vestibular activities. Cawthorne-Cooksey exercises, originally developed for vestibular rehabilitation, focus on eye-head-body coordination and postural adaptation. When adapted for cervical use, they may enhance neuromuscular control, improve cervical joint position sense, and promote motor learning. These exercises are made to compensate for the affected vestibular signals (which cause poor balance and coordination) by retraining the eye and body musculatures.
Other: Cawthorne-Cooksey exercises

Cawthorne-Cooksey exercises are one form of vestibular exercises under this training involving centers such as visual, proprioceptive, and vestibular activities.

Cawthorne-Cooksey exercises, originally developed for vestibular rehabilitation, focus on eye-head-body coordination and postural adaptation. When adapted for cervical use, they may enhance neuromuscular control, improve cervical joint position sense, and promote motor learning. These exercises are made to compensate for the affected vestibular signals (which cause poor balance and coordination) by retraining the eye and body musculatures.

Other: Therapeutic Ultrasound
The application of ultrasound therapy with patient prone lying position paravertebral in posterior aspect of neck. The Treatment parameter ( 1 MHZ, FR 100HZ , duty factor 75% , power intensity 1.5w/cm2 , continuous mode , treatment time 5 min ).
Experimental: Therapeutic Ultrasound

Therapeutic Ultrasound:

The application of ultrasound therapy with patient prone lying position paravertebral in posterior aspect of neck. The Treatment parameter ( 1 MHZ, FR 100HZ , duty factor 75% , power intensity 1.5w/cm2 , continuous mode , treatment time 5 min ).
Other: Therapeutic Ultrasound
The application of ultrasound therapy with patient prone lying position paravertebral in posterior aspect of neck. The Treatment parameter ( 1 MHZ, FR 100HZ , duty factor 75% , power intensity 1.5w/cm2 , continuous mode , treatment time 5 min ).

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Cervical Proprioception
Time Frame: From enrollment to the end of treatment at 8 weeks

Measuring Neck Proprioception by cervical joint position error via overhead laser pointer :

  1. Laser pointer: will be fixed to the subject's head by a strap to determine the degree of error in the test .
  2. Target paper: typically, 40 cm in diameter that contains concentric circles in 1 cm increments, divided into 4 quadrants intersecting at zero .
  3. Chair: a stable chair with back support and positioned such that it will not move when the subject will move his/her head during the test.
  4. Colored stickers: will be used to determine the starting and the ending points of the laser.
  5. Ruler: to measure the distance between the start point and endpoint in each direction on the target paper.
From enrollment to the end of treatment at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
German International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 15, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 15, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 15, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 24, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 24, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 7, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 13, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 11, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • P.T.REC/012/006093

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Radiculopathy

Clinical Trials on Cawthorne-Cooksey exercises

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings